DNMT1 and cancer: The DNMT inhibitor SGI-1027, the safety of which was validated in a rat hepatoma (H4IIE) cell line, decreased methylation by inhibiting the activity of DNMT3B.41 This DNMT inhibitor might upregulate HOXB13 expression by decreasing methylation in cancer cells.